Metformin and colchicine for post-COVID condition: baseline results from the RECLAIM adaptive platform trial | Julie Schoevers
The session recording is not yet available.
Video on Demand
Get access to 100 conference recordings. Choose the access option that fits you: patients, early-career researchers, professionals and industry. Watch the sessions that matter most to you, whenever it suits you.
Thu 27 Aug
15:04
10 min
Abstract #58
Church Hall
Clinical Track
Metformin and colchicine for post-COVID condition: baseline results from the RECLAIM adaptive platform trial
This presentation introduces RECLAIM, a nationwide adaptive clinical trial evaluating repurposed medicines for people with Post-COVID Condition. Using a fully remote study design, RECLAIM aims to identify safe and effective treatments while demonstrating an innovative model for accelerating clinical research and improving access for people living with Long COVID.
Julie Schoevers | Physician-Researcher and PhD Candidate
University Medical Center Utrecht, the Netherlands
Presentation slides are not yet available.